Skip to main content

and
Your search also matched 1 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Modeling NSCLC Progression: Recent Advances and Opportunities Available

Include preview-only content
  1. Article

    A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients

    Treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor used for treating non-small-cell lung cancer (NSCLC) and other cancers, is frequently associated with adverse events (AE)...

    Ahmed Abbas Suleiman, Sebastian Frechen, Matthias Scheffler in The AAPS Journal (2015)